These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 9287319

  • 21. Cytokine induction by purified lipoteichoic acids from various bacterial species--role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release.
    Hermann C, Spreitzer I, Schröder NW, Morath S, Lehner MD, Fischer W, Schütt C, Schumann RR, Hartung T.
    Eur J Immunol; 2002 Feb; 32(2):541-51. PubMed ID: 11828371
    [Abstract] [Full Text] [Related]

  • 22. Lipopolysaccharide stimulates HepG2 human hepatoma cells in the presence of lipopolysaccharide-binding protein via CD14.
    Nanbo A, Nishimura H, Muta T, Nagasawa S.
    Eur J Biochem; 1999 Feb; 260(1):183-91. PubMed ID: 10091598
    [Abstract] [Full Text] [Related]

  • 23. An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation.
    Gioannini TL, Zhang D, Teghanemt A, Weiss JP.
    J Biol Chem; 2002 Dec 06; 277(49):47818-25. PubMed ID: 12372833
    [Abstract] [Full Text] [Related]

  • 24. Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14.
    Kim SJ, Kim HM.
    BMB Rep; 2017 Feb 06; 50(2):55-57. PubMed ID: 28115037
    [Abstract] [Full Text] [Related]

  • 25. Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS.
    Thompson PA, Tobias PS, Viriyakosol S, Kirkland TN, Kitchens RL.
    J Biol Chem; 2003 Aug 01; 278(31):28367-71. PubMed ID: 12754215
    [Abstract] [Full Text] [Related]

  • 26. The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes.
    Pahwa R, Devaraj S, Jialal I.
    Int J Obes (Lond); 2016 Jun 01; 40(6):907-11. PubMed ID: 26880233
    [Abstract] [Full Text] [Related]

  • 27. Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: structural requirements differ from those for responses to lipopolysaccharide.
    Dziarski R, Viriyakosol S, Kirkland TN, Gupta D.
    Infect Immun; 2000 Sep 01; 68(9):5254-60. PubMed ID: 10948152
    [Abstract] [Full Text] [Related]

  • 28. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14.
    Gegner JA, Ulevitch RJ, Tobias PS.
    J Biol Chem; 1995 Mar 10; 270(10):5320-5. PubMed ID: 7534294
    [Abstract] [Full Text] [Related]

  • 29. Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria.
    Lengacher S, Jongeneel CV, Le Roy D, Lee JD, Kravchenko V, Ulevitch RJ, Glauser MP, Heumann D.
    J Inflamm; 1995 Mar 10; 47(4):165-72. PubMed ID: 9144073
    [Abstract] [Full Text] [Related]

  • 30. Differences in LPS-induced activation of bronchial epithelial cells (BEAS-2B) and type II-like pneumocytes (A-549).
    Schulz C, Farkas L, Wolf K, Kratzel K, Eissner G, Pfeifer M.
    Scand J Immunol; 2002 Sep 10; 56(3):294-302. PubMed ID: 12193231
    [Abstract] [Full Text] [Related]

  • 31. Binding of bacterial peptidoglycan to CD14.
    Dziarski R, Tapping RI, Tobias PS.
    J Biol Chem; 1998 Apr 10; 273(15):8680-90. PubMed ID: 9535844
    [Abstract] [Full Text] [Related]

  • 32. Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes.
    Vesy CJ, Kitchens RL, Wolfbauer G, Albers JJ, Munford RS.
    Infect Immun; 2000 May 10; 68(5):2410-7. PubMed ID: 10768924
    [Abstract] [Full Text] [Related]

  • 33. Modulatory effects of sCD14 and LBP on LPS-host cell interactions.
    Kitchens RL, Thompson PA.
    J Endotoxin Res; 2005 May 10; 11(4):225-9. PubMed ID: 16176659
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro.
    Goldblum SE, Brann TW, Ding X, Pugin J, Tobias PS.
    J Clin Invest; 1994 Feb 10; 93(2):692-702. PubMed ID: 7509346
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.
    Kitchens RL, Ulevitch RJ, Munford RS.
    J Exp Med; 1992 Aug 01; 176(2):485-94. PubMed ID: 1380063
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex.
    Baveye S, Elass E, Fernig DG, Blanquart C, Mazurier J, Legrand D.
    Infect Immun; 2000 Dec 01; 68(12):6519-25. PubMed ID: 11083760
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.